SIShoulder Innovations Inc

Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire GRAND RAPIDS, Mich., May 26, 2026 GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ --Shoulder...

The average of price targets set by Wall Street analysts indicates a potential upside of 36% in Shoulder Innovations, Inc. (SI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Shoulder Innovations, Inc. (SI) delivered earnings and revenue surprises of +6.82% and +16.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

read more...

Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook PR...

Viatris (VTRS) delivered earnings and revenue surprises of +13.46% and +4.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs (ESTA) delivered earnings and revenue surprises of -40.35% and +4.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) delivered earnings and revenue surprises of +80.00% and +1.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Shares of Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold r...